Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.064 | 0.7 |